Reynolds American Inc. has announced the submission of a group of Premarket Tobacco Product Applications (PMTAs) to the US Food and Drug Administration (FDA) seeking orders authorising the marketing of VELO pouches.

The VELO pouch, which is made with nicotine derived from tobacco but contains no tobacco leaf, is a small, white pouch that is placed between an adult tobacco consumer’s gum and lip. The submitted group of applications includes varying nicotine strength levels and two flavours for VELO pouch products. A grant of these marketing orders would allow these products to remain on the market after FDA review, a company press release said.
“VELO represents an innovative space for us to identify what adult tobacco consumers want next – thus submitting the final group of VELO brand PMTAs was a great next step to help ensure adult tobacco consumers have consumer-acceptable products available that provide them with lifestyle choices and varying nicotine levels that make sense,” stated Reynolds’ Executive Vice President and Head of Scientific & Regulatory Affairs, Dr. James Figlar.
The PMTAs for VELO pouches are part of Reynolds’ ongoing submissions to the FDA seeking marketing orders, following applications for VELO lozenges and Vuse Vibe, Ciro and Solo electronic nicotine delivery systems.